Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
Sponsor: Addpharma Inc.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.
Official title: A Randomized, Open-label, Multiple Oral-dose, 2x2 Crossover Clinical Trial to Compare the Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a AD-120 and AD-120A in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2025-04-21
Completion Date
2025-09-01
Last Updated
2025-04-08
Healthy Volunteers
Yes
Conditions
Interventions
AD-120A
Administered before the breakfast during 7 days, Oral, Tablet
AD-120
Administered before the breakfast during 7 days, Oral, Tablet
Locations (1)
Seoul National University Hospital
Seoul, South Korea